Illumina, Inc. vs Lockheed Martin Corporation — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Lockheed Martin Corporation trades at $597.49 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 4.7× Illumina, Inc.'s market cap, and Lockheed Martin Corporation pays a 2.31% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | LMT | |
|---|---|---|
Market Cap | $29.12B | $137.96B |
Sector | Health | Industrials |
52-Week High | $205.10 | $676.70 |
52-Week Low | $91.00 | $431.56 |
Enterprise Value | $30.48B | $154.71B |
Dividend Yield | — | 2.31% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →